PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
01-Dec-2019 Agfa Launches DR 100s: A New Force in Mobile DR Agfa N.V.
29-Nov-2019 Announcement under the Irish Takeover Rules: Relevant Securities in Issue - November 29, 2019 Allergan plc
29-Nov-2019 Epigenomics AG: New Micro-Simulation Study in Cancer Medicine Finds Epi proColon(R) Provides Clinically Meaningful Reductions in Incidence and Mortality of Colorectal Cancer Epigenomics AG
29-Nov-2019 National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication Shenzhen Chipscreen Biosciences, Ltd.
29-Nov-2019 CollPlant Reports Third Quarter 2019 Financial Results and Provides Business Update CollPlant
29-Nov-2019 Ascletis successfully obtained Pharmaceutical Trade License and GSP Certificate, formed a Complete Commercial Layout Ascletis Pharma Inc.
28-Nov-2019 Registration Opens for SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference SMi Group
28-Nov-2019 One Nucleus announces finalists of the BioNewsRound Award One Nucleus
28-Nov-2019 Original-Research: MagForce AG (von GBC AG) MagForce AG
28-Nov-2019 Vivoryon Therapeutics AG: Vivoryon Therapeutics Reports Third Quarter 2019 Vivoryon Therapeutics AG
28-Nov-2019 Mundipharma CEO Raman Singh Wins Executive of The Year at SBR Management Excellence Awards Mundipharma
27-Nov-2019 Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050 Pfizer Inc.
27-Nov-2019 Return of XonveaTM Licensing Rights ALLIANCE PHARMA PLC
27-Nov-2019 Registration is Now Open for Pre-Filled Syringes East Coast Conference SMi Group
27-Nov-2019 Vivoryon Therapeutics AG: Vivoryon Therapeutics attends CTAD 2019 Vivoryon Therapeutics AG
27-Nov-2019 AEVIS VICTORIA SA: Development of the hotel segment AEVIS VICTORIA SA
26-Nov-2019 FDA In Brief: FDA issues warning letter for products illegally marketed for the treatment of health conditions, including opioid withdrawal symptoms U.S. Food and Drug Administration
26-Nov-2019 Karuna Therapeutics Announces KarXT Met Primary Endpoint in Phase 2 Clinical Trial of Acute Psychosis in Patients with Schizophrenia Karuna Therapeutics, Inc.
26-Nov-2019 DiaMonTech AG postpones IPO DiaMonTech AG
26-Nov-2019 Vaccitech provides update on clinical progress for its two Phase 2 Universal Influenza studies Vaccitech Ltd